Ritonavir

CAS 155213-67-5 17 current records 4 historicalSmall Molecule

Who holds supplier records for Ritonavir? 17 organisations hold a current record for Ritonavir: an active US FDA Type II Drug Master File or a CEP. A further 4 organisations have only historical (inactive) DMF filings. 9 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (11), China (2), Italy (1) and United States (1); not recorded for 2.

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Ritonavir: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/ritonavir

Reading the evidence

  • 17 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    11 of the 15 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 9 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (17)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Ritonavir. Country is the organisation's recorded country, not necessarily the manufacturing site.

India11China2Italy1United States1Country not recorded for 2
  • Hetero Drugs Limited
    Active DMF 24629, 20270, 26178 · latest filing Jun 2012
    IndiaCEP Company GMP cert on record
  • APITORIA PHARMA PRIVATE LTD
    Active DMF 19037 · latest filing Dec 2005
    IndiaCEP Company GMP cert on record
  • Arene Life Sciences Limited
    Active DMF 34846 · latest filing May 2020
    IndiaCEP
  • CHROMO LABORATORIES INDIA PRIVATE LTD
    Active DMF 35303 · latest filing Nov 2020
    IndiaCEP
  • Laurus Labs Limited
    Active DMF 33342 · latest filing Aug 2019
    IndiaCEP Company GMP cert on record
  • MATRIX PHARMACORP PRIVATE LTD
    Active DMF 19800 · latest filing Sept 2006
    IndiaCEP
  • Shanghai Desano Chemical Pharmaceutical Co., Ltd
    Active DMF 24383 · latest filing Dec 2010
    ChinaCEP
  • Cipla Limited
    Active DMF 26443 · latest filing Jan 2013
    India Company GMP cert on record
  • Dr. Reddy's Laboratories Ltd.
    Active DMF 23591 · latest filing Mar 2010
    India Company GMP cert on record
  • Emcure Pharmaceuticals Limited
    Active DMF 26463, 24030 · latest filing Oct 2012
    India Company GMP cert on record
  • Hetero Labs Limited
    Active DMF 33478 · latest filing May 2019
    India Company GMP cert on record
  • LUPIN MANUFACTURING SOLUTIONS LTD
    Active DMF 37050 · latest filing Apr 2022
  • OLON SPA
    Active DMF 23935 · latest filing Jun 2010
    Italy Company GMP cert on record
  • RAKS PHARMA PVT LTD
    Active DMF 28128 · latest filing Mar 2014
    India
  • RUYUAN HEC PHARM CO LTD
    Active DMF 36673 · latest filing Jan 2022
  • United StatesCEP Company GMP cert on record
  • ANHUI BIOCHEM PHARMACEUTICAL CO., LTD.
    Valid CEP holder (EDQM); not necessarily the manufacturer
    ChinaCEP
Need Ritonavir sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (9)

Certificates of Suitability on the EDQM register for Ritonavir, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 12 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang TownCN
CEP 2020-416 - Rev 01
Ritonavir, Form-II
Jul 2026—
MATRIX PHARMACORP PRIVATE LIMITED Sangareddy DistrictIN
CEP 2011-346 - Rev 02
Ritonavir, Form-I
Oct 2025—
ANHUI BIOCHEM PHARMACEUTICAL CO., LTD. FuyangCN
CEP 2022-394 - Rev 00
Ritonavir
Dec 2024—
HETERO DRUGS LIMITED HyderabadIN
CEP 2020-235 - Rev 01
Ritonavir, Form-I
Dec 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2018-061 - Rev 02
Ritonavir
Oct 2024—
ARENE LIFE SCIENCES PRIVATE LIMITED SangareddyIN
CEP 2022-293 - Rev 00
Ritonavir
Jan 2024—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
R0-CEP 2020-345 - Rev 00
Ritonavir
Mar 2023—
LAURUS LABS LIMITED HyderabadIN
R0-CEP 2020-102 - Rev 01
Ritonavir
Mar 2023—
AbbVie Inc. North ChicagoUS
R1-CEP 2012-397 - Rev 00
Ritonavir
Sept 2019—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (4)

Organisations whose Type II DMFs for Ritonavir are no longer active. These show a past filing, not current supply.

Show all 4 historical records
  • India · Inactive DMF 23542 · filed Mar 2010
  • RANBAXY LABORATORIES LTD
    Inactive DMF 21145 · filed Dec 2007
  • MYLAN LABORATORIES LTD
    Inactive DMF 19839 · filed Oct 2006
  • France · Inactive DMF 11666 · filed Sept 1995

Overview

Ritonavir is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL163).

Chemical identity

IUPAC name
1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate
Canonical SMILES
CC(C)C1=NC(=CS1)CN(C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC2=CC=CC=C2)C[C@@H]([C@H](CC3=CC=CC=C3)NC(=O)OCC4=CN=CS4)O
InChIKey
NCDNCNXCDXHOMX-XGKFQTDJSA-N
Synonyms
A-84538, ABBOTT-84538, ABT-538, Empetus, Norvir, NSC-693184, Ritomune, Ritonavir, Ritonavir component of kaletra, Ritonavir component of paxlovid, Ritonavir component of technivie, Ritonavir component of viekirax

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Cytochrome P450 3A Inhibitor; Protease Inhibitor
Mechanism of action
Breast Cancer Resistance Protein Inhibitors; Cytochrome P450 1A2 Inducers; Cytochrome P450 2B6 Inducers; Cytochrome P450 2C19 Inducers; Cytochrome P450 2C9 Inducers; Cytochrome P450 2D6 Inhibitors; Cytochrome P450 3A Inducers; Cytochrome P450 3A Inhibitors; Cytochrome P450 3A4 Inhibitors; HIV Protease Inhibitors; P-Glycoprotein Inhibitors; UDP Glucuronosyltransferases Inducers

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Ritonavir?

17 organisations hold an active US FDA Type II Drug Master File or a CEP for Ritonavir: Hetero Drugs Limited (India), APITORIA PHARMA PRIVATE LTD (India), Arene Life Sciences Limited (India), CHROMO LABORATORIES INDIA PRIVATE LTD (India), Laurus Labs Limited (India), MATRIX PHARMACORP PRIVATE LTD (India), Shanghai Desano Chemical Pharmaceutical Co., Ltd (China) and Cipla Limited (India), and 9 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Ritonavir Drug Master Files are active?

Hetero Drugs Limited (DMF 24629, 20270), APITORIA PHARMA PRIVATE LTD (DMF 19037), Arene Life Sciences Limited (DMF 34846), CHROMO LABORATORIES INDIA PRIVATE LTD (DMF 35303), Laurus Labs Limited (DMF 33342), MATRIX PHARMACORP PRIVATE LTD (DMF 19800), Shanghai Desano Chemical Pharmaceutical Co., Ltd (DMF 24383) and Cipla Limited (DMF 26443) and 7 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Ritonavir records mean?

4 organisations have only inactive Type II DMFs for Ritonavir. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Ritonavir have a European Certificate of Suitability?

Yes. 9 organisations hold a valid CEP for Ritonavir on the EDQM register, including SHANGHAI DESANO CHEMICAL PHARMACEUTICAL CO., LTD. Laogang Town (CN), MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District (IN), ANHUI BIOCHEM PHARMACEUTICAL CO., LTD. Fuyang (CN), HETERO DRUGS LIMITED Hyderabad (IN), APITORIA PHARMA PRIVATE LIMITED Hyderabad (IN) and ARENE LIFE SCIENCES PRIVATE LIMITED Sangareddy (IN) and 3 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Ritonavir supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Ritonavir?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.